Concomitant use of sivelestat sodium hydrate and antithrombotic drugs worsens the treatment outcome of patients with acute respiratory distress syndrome and suppression of fibrinolysis: a single-center, retrospective study

Concomitant use of sivelestat sodium hydrate and antithrombotic drugs worsens the treatment outcome of patients with acute respiratory distress syndrome and suppression of fibrinolysis: a single-center, retrospective study

Objectives: Sivelestat sodium hydrate (SSH) may be effective in the early stage of acute respiratory distress syndrome (ARDS) before the neutrophil extracellular trap scaffold structure is complete. Therefore, patients with suppression of fibrinolysis (SF) before the secondary fibrinolytic process m...

Full description

Saved in:
Bibliographic Details
Main Authors: Takahiro Kato, Tomohiro Mizuno, Takenao Koseki, Kazuo Takahashi, Shigeki Yamada, Kazuyoshi Imaizumi, Naotake Tsuboi, Naozumi Hashimoto
Format: Article
Language:English
Published: Fujita Medical Society 2025-08-01
Series:Fujita Medical Journal
Subjects:
acute respiratory distress syndrome
sivelestat sodium hydrate
fibrinolysis suppression
antithrombotic drug
Online Access:https://www.jstage.jst.go.jp/article/fmj/11/3/11_2024-026/_pdf/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.jstage.jst.go.jp/article/fmj/11/3/11_2024-026/_pdf/-char/en

Similar Items